U.S. Markets open in 4 hrs 37 mins

AzurRx BioPharma, Inc. (AZRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7943+0.0198 (+2.56%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.83
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.9380
52 Week Low 30.3710
50-Day Moving Average 30.7565
200-Day Moving Average 30.8480

Share Statistics

Avg Vol (3 month) 3146.63k
Avg Vol (10 day) 3162.7k
Shares Outstanding 530.41M
Float 26.19M
% Held by Insiders 111.09%
% Held by Institutions 15.15%
Shares Short (Nov 12, 2020) 462.82k
Short Ratio (Nov 12, 2020) 40.52
Short % of Float (Nov 12, 2020) 40.21%
Short % of Shares Outstanding (Nov 12, 2020) 40.21%
Shares Short (prior month Oct 14, 2020) 4213.87k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-48.55%
Return on Equity (ttm)-191.73%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-24.71M
Diluted EPS (ttm)-0.8990
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.37M
Total Cash Per Share (mrq)0.37
Total Debt (mrq)105.62k
Total Debt/Equity (mrq)0.75
Current Ratio (mrq)4.39
Book Value Per Share (mrq)0.49

Cash Flow Statement

Operating Cash Flow (ttm)-8.56M
Levered Free Cash Flow (ttm)-3.29M